| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $0.68 | - | - |
| Q1'26 | $0.62 | $0.67 | +8.3% |
| Q4'25 | $0.71 | $0.72 | +1.3% |
| Q3'25 | $0.71 | $0.73 | +2.9% |
| Q2'25 | $0.68 | $0.73 | +7.9% |
| Q1'25 | $0.66 | $0.74 | +12.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $9.4B | - | - |
| Q1'26 | $9.9B | $10.1B | +1.4% |
| Q4'25 | $10.5B | $10.5B | -0.2% |
| Q3'25 | - | - | - |
| Q2'25 | - | $9.0B | - |
| Q1'25 | - | $9.3B | - |
Market Data
MDLZ is currently trading at $62.47, giving Mondelez International, Inc. a market cap of 79.28B and a P/E ratio of 30.3. Today's range spans $61.42–$62.52, with shares opening at $62.14 and moving up $0.71 (1.1%) from the prior close. DailyIQ's technical score sits at 77/100 (BUY) with a news sentiment reading of 58/100.
Over the past year MDLZ has traded between $51.20 and $71.15 - the current price is +22.0% off the 52-week low and -12.2% from the high.
In the Consumer Defensive peer group, Mondelez International, Inc. (MDLZ) stands out for a BUY signal backed by aligned sentiment - score 77/100, sentiment neutral at 58/100, price $62.47 (in the middle of its 52-week range). (P/E: 30.3) With 79.28B in market cap, this is large enough to feature on institutional watch lists but small enough to re-rate meaningfully on a positive earnings surprise. The 52-week span of $51.20–$71.15 shows the stock has already proven it can make significant moves.
What makes MDLZ's BUY setup (77/100) particularly actionable at 79.28B in Consumer Defensive capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $62.47 (in the middle of its 52-week range in $51.20–$71.15), with sentiment running neutral at 58/100, the setup rewards conviction-sized positioning more than it does speculative small bets.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines